2021
DOI: 10.21203/rs.3.rs-1162693/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Use of non-invasive sensor to assess intracranial compliance in the management of migraine patients: case report

Abstract: The objective of this study is to report the use of a non-invasive sensor to assess intracranial compliance (ICC) in patients complaining of migraine. This case report presents a 34-year-old, female patient that was treated for idiopathic intracranial hypertension (IIH) by placing a non-adjustable lumboperitoneal shunt. After one year, she presented with headache and signs of overdrainage. Non-invasive monitoring of ICC was done, suggesting a reduction in the ICC, but no change in the opening pressure of the v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Apart from experimental and non-original papers, most of these articles were piloting the use of the device in patients with various neurological and non-neurological conditions. These included cryptococcal meningitis [5], renovascular hypertension [26], pediatric hydrocephalus [2], obesity [8], critical COVID-19 [10], end-stage renal disease [41], pregnancy [19], patients sedated for gastrointestinal endoscopy [24], sedentary chronic stroke patients [40], hemodialysis patients [42], prostatectomy surgery patients [45], fibromyalgia [33], cardiovascular surgery patients [1], diabetes and chronic kidney disease [35], and migraine [14]. To the best of our knowledge, this is the first prospective study to compare the Brain4Care noninvasive method with the invasive gold standard in TBI.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from experimental and non-original papers, most of these articles were piloting the use of the device in patients with various neurological and non-neurological conditions. These included cryptococcal meningitis [5], renovascular hypertension [26], pediatric hydrocephalus [2], obesity [8], critical COVID-19 [10], end-stage renal disease [41], pregnancy [19], patients sedated for gastrointestinal endoscopy [24], sedentary chronic stroke patients [40], hemodialysis patients [42], prostatectomy surgery patients [45], fibromyalgia [33], cardiovascular surgery patients [1], diabetes and chronic kidney disease [35], and migraine [14]. To the best of our knowledge, this is the first prospective study to compare the Brain4Care noninvasive method with the invasive gold standard in TBI.…”
Section: Discussionmentioning
confidence: 99%